Aramark · ARMK · FY2026 Q4 · Calendar Q4 2026

Aramark Posts Record FY2026, Targets 9–10% Organic Growth in FY2027

Record FY2026 performance, strong client wins and retention, and Nexus's planned contribution underpin Aramark's maintained growth outlook. The key test is whether new-business momentum and Nexus scaling translate into durable growth and margin expansion; the supplied scorecard's slight consensus shortfalls and the execution and cash-conversion questions temper the positive operating picture.

Why did ARMK rise 2.7% after missing EPS estimates in FY2026 Q4?

Research this report with FN2. Free to start; review your question before sending.

Reported Before market openNYSEIndustrials $14.61B market cap
100quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.71 Consensus $0.76
EPS surprise -6.0% Reported versus consensus
Reported revenue $5.29B Consensus $5.30B
Revenue surprise -0.2% Reported versus consensus
Check the math in the surprise calculator >

Market reaction

prior-close to event-session close
Stock move +2.7% Event window
SPY move -1.9% Same window
Abnormal move +4.6% Stock minus SPY
Volume 2.0× Versus trailing sessions
Subsequent drift 0.0% Up to 20 sessions
ARMKSPY benchmark

Ask FN2 about ARMK FY2026 Q4

Choose a question to continue your research

Free to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.

Transcript intelligence

What changed

The supplied analysis moves the story from Q3's early Nexus rollout and raised FY2026 growth outlook to FY2026's record results and a maintained FY2027 outlook. Nexus is now described as contributing to growth, with management expecting $500 million of revenue from it in FY2027. The analysis also highlights a 6.8% net-new growth rate, $1.9 billion of gross new-client wins, and enhanced shareholder returns.

Guidance delta

Management maintained its FY2027 outlook, targeting 9–10% organic revenue growth and continued margin expansion. The supplied analysis does not describe a change to that outlook.

Key takeaways

  • Management characterized FY2026 as a record year for revenue, operating income and free cash flow, supported by strong net-new business and client retention.
  • Aramark reported a 6.8% net-new growth rate and $1.9 billion in gross new-client wins, according to the supplied transcript analysis.
  • Nexus contributed to organic growth; management expects it to add $500 million of revenue in FY2027.
  • The supplied scorecard shows EPS and revenue modestly below consensus, while management maintained its FY2027 outlook.

Management priorities

  • Scale Nexus across additional hyperscaler and workforce-housing locations.
  • Expand collegiate, healthcare and workplace-service contracts and sustain new-business momentum.
  • Use Avendra International and other supply-chain efficiencies to support operations.
  • Maintain disciplined capital spending while returning capital through dividends and repurchases.

Follow ARMK with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
ARMK REVENUE earnings history estimate and actual scatter chart 10 reported fiscal quarters and 2 future estimate-only quarters. Q4 '23 estimate $5B Q4 '23 actual $5B, beat Q1 '24 estimate $4B Q1 '24 actual $4B, beat Q2 '24 estimate $4B Q2 '24 actual $4B, miss Q3 '24 estimate $4B Q3 '24 actual $4B, miss Q3 '25 estimate $5B Q3 '25 actual $5B, miss Q4 '25 estimate $5B Q4 '25 actual $5B, miss Q1 '26 estimate $5B Q1 '26 actual $5B, beat Q2 '26 estimate $5B Q2 '26 actual $5B, beat Q3 '26 estimate $5B Q3 '26 actual $5B, beat Q4 '26 estimate $5B Q4 '26 actual $5B, miss Q1 '27 estimate $5B Q2 '27 estimate $5B
Show less

Analyst Consensus ?

ConsensusBuy24 ratings
Bullish2187.5%
Neutral28.3%
Bearish14.2%

Analyst 52W Price Targets

$53.84Current
$33Low
$57.15Average
$74High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
UBS Buy BuyMaintainNov 11, 2026
Citigroup Buy BuyMaintainOct 12, 2026
RBC Capital Outperform OutperformMaintainAug 19, 2026
JP Morgan Overweight OverweightMaintainAug 13, 2026
Stifel Buy BuyMaintainAug 12, 2026
Show 19 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $53.84. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
UBSJoshua Chan$65$54.14 +20.7%Nov 11, 2026
Bank of America SecuritiesAnalyst unavailable$69$54.39 +28.2%Oct 26, 2026
RBC CapitalAnalyst unavailable$70$60.23 +30.0%Aug 19, 2026
New StreetAnalyst unavailable$70$60.35 +30.0%Aug 13, 2026
JefferiesAnalyst unavailable$70$61.24 +30.0%Aug 12, 2026
See 44 more

Track every rating change on ARMK the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Based in Philadelphia, Pennsylvania, Aramark, established in 1959, provides a comprehensive array of services encompassing food management, facility solutions, and uniform provision. The company serves a diverse global clientele, including educational institutions, healthcare providers, various businesses and industrial clients, sports and entertainment venues, leisure operators, and correctional facilities, both within the United States and internationally. Aramark organizes its operations into three primary divisions: U.S. Food and Support Services, International Food and Support Services, and Uniform and Career Apparel. Its extensive food-related offerings feature managed dining programs, catering solutions, food service management, and convenience retail options. This includes operating on-site restaurants, providing executive dining experiences, managing convenience stores, and offering beverage and vending services.…

Historical context

All ARMK earnings

Industrials peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the ARMK recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-11-16T17:10:32.528493+00:00
  2. FN2 earnings calendar · 2026-11-17T01:23:14.281446+00:00
  3. Polygon adjusted daily market bars · 2026-11-17T05:30:49.948906+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-17T05:30:49.946185+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-11-17. For educational purposes only; not investment advice.